fMRI-Guided aTMS Lifts Depression Response to 80% From 60% in 40-Patient Trial

Q: Can artificial intelligence eliminate the need for costly brain scans in this new depression therapy?

Not yet. In the Harvard–Mass General Brigham trial, the better results came from using each patient’s own fMRI scan to guide where accelerated TMS was delivered. Patients targeted this way had higher response rates than those treated with standard scalp-based measurements, so the scan was not optional in the method that showed the benefit. What AI may do is reduce how much imaging is needed, not eliminate it today. Researchers say the next step is to test whether the lengthy 41-minute fMRI protocol can be simplified and whether AI-assisted, atlas-based, or normative connectomic models can predict the best target from cheaper or more widely available data. That could make the approach more scalable if full individual imaging is not feasible. But there is no evidence yet that AI can replace brain scans without sacrificing accuracy. The current study did not test an AI-only targeting method against fMRI-guided targeting. In fact, its main finding was that personalized neuroimaging improved outcomes over conventional targeting. So the practical answer is that AI is a promising tool for lowering cost and expanding access in the future, but for this specific TMS approach, costly brain scans remain the proven way to personalize treatment. Larger trials will be needed to show whether AI-based shortcuts can match the clinical gains seen with direct imaging.

3 articles · Updated · Brain and Behavior Research · Jul 9

A randomized blinded trial in 40 treatment-resistant major depression patients found connectivity-guided accelerated TMS produced stronger 1-month outcomes than conventional scalp-based targeting, with 80% achieving clinical response versus 60%.
The advantage came from using each patient's resting-state fMRI to identify the dorsolateral prefrontal cortex site most strongly connected to a previously mapped whole-brain depression circuit, rather than relying on standard scalp measurements.
Both groups received the same intensive regimen—10 stimulation sessions a day for 5 days, totaling 90,000 pulses—with live neuronavigation, isolating target selection as the key difference.
The researchers said the public-data-based targeting approach could be more scalable than proprietary methods, but the 41-minute fMRI scan may limit cost and access.
Published in JAMA Psychiatry, the study provides rare head-to-head patient evidence for neuroimaging-guided psychiatric treatment, though the team said larger trials must confirm the benefit and test whether shorter scans or other imaging methods work as well.

Sources

Brain and Behavior Research4d ago

fMRI-Guided Accelerated TMS Outperforms Conventional Targeting for Major Depression

sciencedirect.com4d ago

Transcranial direct current stimulation alleviates depression-like behaviors by activating the ACC-ZI neural circuit - ScienceDirect

link.springer.com4d ago

Frequency-decomposed EEG microstate analysis reveals altered cross-frequency coordination in adolescent major depressive disorder | European Archives of Psychiatry and Clinical Neuroscience | Springer Nature Link

4 Sources

Why does targeting this newly-mapped brain circuit provide superior depression relief over other methods?

Can artificial intelligence eliminate the need for costly brain scans in this new depression therapy?

This breakthrough shows an 80% response rate, but will it become accessible for most patients?

fMRI-Guided Accelerated TMS Achieves Over 80% Response Rate in Treatment-Resistant Depression: Mechanisms, Evidence, and Future Directions

Overview

Recent breakthroughs in depression treatment have shown that fMRI-guided accelerated Transcranial Magnetic Stimulation (aTMS) offers significant hope for people with treatment-resistant depression. This approach builds on foundational research into circuit-targeted modulation, allowing doctors to use fMRI data to precisely target specific brain circuits linked to depression and anxiety. By moving beyond conventional, less individualized TMS methods, fMRI-guided aTMS delivers more personalized and effective care. The core mechanism behind this innovation is its ability to tailor treatment to each person's unique brain patterns, marking a crucial step forward in mental health care.

...